USFDA pulls up Sun Pharma for lapses in Halol plant

"This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals... Because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, your drug products are adulterated," the USFDA stated.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7LcwTzt
via IFTTT